Lymphotactin inhibitors are chemical compounds that target lymphotactin, also known as XCL1 (X-C Motif Chemokine Ligand 1). Lymphotactin is a small chemokine, a type of signaling molecule that plays a crucial role in the immune system's regulation by attracting immune cells, such as T cells and dendritic cells, to sites of inflammation and infection. It is secreted by activated T cells and binds to its receptor, XCR1, on target immune cells. Lymphotactin is involved in orchestrating immune responses, immune cell trafficking, and the communication between various immune cell types within the body.
Inhibitors of lymphotactin are designed to interact with this chemokine and potentially disrupt its binding to the XCR1 receptor or affect its signaling activity. These inhibitors may operate through various mechanisms, such as binding to specific regions of lymphotactin or altering its conformation. By inhibiting lymphotactin, these compounds can potentially interfere with the recruitment and activation of immune cells at sites of inflammation or infection. Research on lymphotactin inhibitors is primarily focused on understanding the molecular mechanisms by which lymphotactin functions in immune responses and cell trafficking, shedding light on the complexities of the immune system's regulatory pathways and the communication between immune cells during immune surveillance and defense mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid receptor agonist that can suppress cytokine production and may reduce lymphotactin expression by anti-inflammatory action. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
An aldosterone antagonist with potential anti-inflammatory effects that might lead to the downregulation of lymphotactin. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB activation and could decrease lymphotactin expression by reducing pro-inflammatory signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAP kinase inhibitor that may impair inflammatory cytokine production and reduce lymphotactin expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may affect NF-κB signaling and alter the expression of various cytokines, including lymphotactin. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor which could lead to a decrease in ERK pathway signaling, potentially downregulating lymphotactin expression. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
An inhibitor of NF-κB transcriptional activity that may reduce lymphotactin expression by inhibiting NF-κB-mediated transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound that may downregulate NF-κB signaling and could decrease the expression of lymphotactin. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Acetylates cyclooxygenase enzymes and may have an inhibitory effect on inflammatory mediator production, affecting lymphotactin levels. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
A compound found in cruciferous vegetables that may have anti-inflammatory properties and could influence lymphotactin expression. | ||||||